Search Results 1381-1390 of 16036 for Residual

  1. Medical Research & Education - Mayo Clinic News Network

    Glenn Foundation for Medical Research Awards Mayo Clinic $3 Million to Study Biology of Aging. August 20, 2013. Minnesota.

  2. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Platform_Accelerate graduation shows promise of health tech innovation for improving patient care. ROCHESTER, Minn.

  3. Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation (VISTA) - Mayo Clinic

    Prior tricuspid valve surgery or catheter-based therapy with permanent residual devices implanted that would preclude delivery or implantation of the VDyne ...

  4. Recurrent Cancer Clinical Trials - Mayo Clinic Research

    A Study to Evaluate the Surgical Removal of Residual Brain Tumors Prior to Recurrence Rochester, MN. The purpose of this study is to evaluate the safety and ...

  5. Mediterranean diet and brain health Archives - Mayo Clinic News Network

  6. A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity - Mayo Clinic

    About this study. This is an open-label, multi-institutional phase II randomized study comparing neoadjuvant radiotherapy followed by surgical resection to ...

  7. Medical Research & Education - Mayo Clinic News Network

    Search. Request appointment · Sign in. News Releases. Arizona · Minnesota · Florida · International. Health Topics.

  8. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...

  9. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Part A (dose regimen finding) will allow definition of the maximum tolerated dose (MTD) through dose escalation and possible dose interval modification. In Part ...

  10. MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment - Mayo Clinic

    MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure ...